Partnership Opportunities

We partner with cutting-edge service providers and CROs with capabilities in early drug discovery, chemistry, delivery platforms, translational services, and manufacturing. Dedicated to helping the industry overcome existing challenges and progressing this exciting therapeutic modality, and unlocking successful knockdown in extra-hepatic tissues.

It has become increasingly difficult to build relationships with new organizations. Our partners are working with us to build their business development pipelines efficiently. If you’re looking to connect with the key decision-makers at pharma and biotech in gene silencing, this established meeting will provide you with a unique platform to showcase your solutions and elevate your brand awareness.

If you have expertise in this space and would like to align your brand within the RNAi community, please contact us to explore how we can position your brand in front of this dedicated audience through our bespoke commercial packages.

Email to request more information

Confirmed 2023 Attendees:

31670 - Companies Attending
  • Benefit from Market Intelligence

With RNAi therapies continuing to demonstrate consistent positive progressions for therapeutic application, the major hurdle of delivery, translation and targeting beyond the liver remains the sticking point for progression. Hear how and where pharmaceutical giants are looking for services and solutions to facilitate their efforts to produce an effective RNAi - based therapeutics and match your solutions accordingly

  • Meet & Network with Industry Pioneers

With a room full of drug developers and decision makers looking to see how they can effectively advance their exciting early discovery efforts into safe and effective therapeutics, meet prospective clients during structured networking breaks, bespoke 1-2-1 meetings and more informal networking receptions

  • Position Yourself as an Industry Expert

With the emergence of biotech companies focused on developing platforms and tools to successfully harness siRNA for therapeutic application, and with consistent collaborations being formed from large pharma and academics, this meeting is a dedicated platform to put your independent expertise in front of the key decision-makers in the field

  • Raise your Brand Awareness

Benefit from pre- and post-conference exposure to our RNAi KOL community and increase market share through unique branding formats. Also, differentiate your discovery, preclinical and translational and developmental services from other solution providers

  • Generate Commercial Collaborations

Make sure your hottest prospects are in the room and part of the discussion by having a wish-list of your choice contacted in advance of the event